Venture Capital

Updated:

CTBC Venture Capital

CTBC Venture Capital was established in 2003 by Jeffrey Koo Jr. as the venture investment arm tied to CTBC Financial Holding. The Koo family maintains...

CTBC Venture Capital logo

CTBC Venture Capital

CTBC Venture Capital was established in 2003 by Jeffrey Koo Jr. as the venture investment arm tied to CTBC Financial Holding. The Koo family maintains oversight through board roles and related philanthropic vehicles. The firm makes direct equity investments in startups. Confirmed focus areas include IT, biotechnology and healthcare. Activity centers on Taiwan and Hong Kong, with capital deployed via SPVs rather than commingled funds. Team size and AUM remain undisclosed. Jeffrey III joined the board as director in 2022. Adjacent Koo family assets include the CTBC Charity Foundation and Lukang Folk Arts Museum Foundation. Governance flows through the parent CTBC Financial Holding board, creating a direct reporting line uncommon among independent venture managers.

General information

Firm type

Venture Capital

Year founded

2003

AUM

Undisclosed

Location

Region

Asia

Country

Taiwan

City

Taipei

Corporate office

Taipei, Taiwan

Principals

Jeffrey Koo Jr.

Founder

Jeffrey III

Director

Andre Koo

Family Member

Sector focus

ITBiotechnologyHealthcare

Frequently asked questions

Who runs investment decisions at CTBC Venture Capital?

Jeffrey Koo Jr. founded the firm and maintains oversight. Jeffrey III serves as director since 2022.

Does CTBC Venture Capital participate in fund commitments or only direct deals?

The firm executes direct investments in startups through SPVs.

Where does the underlying wealth come from?

Capital originates from CTBC Financial Holding, controlled by the Koo family.

How is CTBC Venture Capital related to CTBC Financial Holding?

CTBC Financial Holding acts as the parent company and primary capital source.

What investment stages does CTBC Venture Capital typically target?

The firm focuses on early-stage startups in IT, biotechnology and healthcare.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Taipei Venture Capital profiles